Akt3 overexpression in the heart results in progression from adaptive to maladaptive hypertrophy.
暂无分享,去创建一个
Masahiro Ito | Y. Taniyama | I. Shiojima | R. Liao | K. Walsh | Kaori Sato | G. Tremp | W. Colucci | Y. Ivashchenko | K. Veit | Christoph Kuester | M. Ito
[1] R. Roth,et al. Akt promotes increased mammalian cell size by stimulating protein synthesis and inhibiting protein degradation. , 2003, American journal of physiology. Endocrinology and metabolism.
[2] J. Stock,et al. Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. , 2003, The Journal of clinical investigation.
[3] Jennifer Skeen,et al. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. , 2003, Genes & development.
[4] C. Kahn,et al. Akt Signaling Mediates Postnatal Heart Growth in Response to Insulin and Nutritional Status* , 2002, The Journal of Biological Chemistry.
[5] Y. Taniyama,et al. Elevated myocardial Akt signaling ameliorates doxorubicin-induced congestive heart failure and promotes heart growth. , 2002, Journal of molecular and cellular cardiology.
[6] J. Ross,et al. Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[7] K. Inoki,et al. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling , 2002, Nature Cell Biology.
[8] C. Sawyers,et al. The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.
[9] J. Blenis,et al. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. , 2002, Molecular cell.
[10] I. Shiojima,et al. Role of Akt Signaling in Vascular Homeostasis and Angiogenesis , 2002, Circulation research.
[11] S. Cook,et al. Phenotypic Spectrum Caused by Transgenic Overexpression of Activated Akt in the Heart* , 2002, The Journal of Biological Chemistry.
[12] P. Kang,et al. Akt/Protein Kinase B Promotes Organ Growth in Transgenic Mice , 2002, Molecular and Cellular Biology.
[13] R. Schwartz,et al. Inhibition of Rho family GTPases by Rho GDP dissociation inhibitor disrupts cardiac morphogenesis and inhibits cardiomyocyte proliferation. , 2002, Development.
[14] M. Birnbaum,et al. Akt1/PKBα Is Required for Normal Growth but Dispensable for Maintenance of Glucose Homeostasis in Mice* , 2001, The Journal of Biological Chemistry.
[15] J. Woodgett,et al. PKB/AKT: functional insights from genetic models , 2001, Nature Reviews Molecular Cell Biology.
[16] I. Roninson,et al. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. , 2001, Genes & development.
[17] D R Alessi,et al. PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? , 2001, Journal of cell science.
[18] B. Hemmings,et al. Two Splice Variants of Protein Kinase Bγ Have Different Regulatory Capacity Depending on the Presence or Absence of the Regulatory Phosphorylation Site Serine 472 in the Carboxyl-terminal Hydrophobic Domain* , 2001, The Journal of Biological Chemistry.
[19] R. Hajjar,et al. Akt Activation Preserves Cardiac Function and Prevents Injury After Transient Cardiac Ischemia In Vivo , 2001, Circulation.
[20] K. Kaestner,et al. Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ) , 2001 .
[21] E. Voest,et al. Doxorubicin and mechanical performance of cardiac trabeculae after acute and chronic treatment: a review. , 2001, European journal of pharmacology.
[22] R. Kitsis,et al. Intracoronary, adenovirus-mediated Akt gene transfer in heart limits infarct size following ischemia-reperfusion injury in vivo. , 2000, Journal of molecular and cellular cardiology.
[23] Mohit M. Jain,et al. Gαi2 but Not Gαi3 Is Required for Muscarinic Inhibition of Contractility and Calcium Currents in Adult Cardiomyocytes , 2000 .
[24] J. Bauer,et al. Cardiac peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice. , 2000, The Journal of pharmacology and experimental therapeutics.
[25] F. Eberli,et al. Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart. , 2000, American journal of physiology. Heart and circulatory physiology.
[26] A. Saraste,et al. Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. , 2000, Cancer research.
[27] W. Koch,et al. Gβγ-dependent Phosphoinositide 3-Kinase Activation in Hearts with in Vivo Pressure Overload Hypertrophy* , 2000, The Journal of Biological Chemistry.
[28] R. Kitsis,et al. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. , 2000, Circulation.
[29] S. R. Datta,et al. Cellular survival: a play in three Akts. , 1999, Genes & development.
[30] J. Wesselink,et al. Molecular cloning, expression and characterization of the human serine/threonine kinase Akt-3. , 1999, European journal of biochemistry.
[31] D. Mann,et al. Mechanisms and models in heart failure: A combinatorial approach. , 1999, Circulation.
[32] W. Liu,et al. Up-regulation of Akt3 in Estrogen Receptor-deficient Breast Cancers and Androgen-independent Prostate Cancer Lines* , 1999, The Journal of Biological Chemistry.
[33] R. Weigel,et al. Identification of a human Akt3 (protein kinase B gamma) which contains the regulatory serine phosphorylation site. , 1999, Biochemical and biophysical research communications.
[34] B. Hemmings,et al. A Human Protein Kinase Bγ with Regulatory Phosphorylation Sites in the Activation Loop and in the C-terminal Hydrophobic Domain* , 1999, The Journal of Biological Chemistry.
[35] P. Singal,et al. Doxorubicin-induced cardiomyopathy. , 1998, The New England journal of medicine.
[36] Lei Wang,et al. Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I. , 1998, Circulation research.
[37] J. Downward. Mechanisms and consequences of activation of protein kinase B/Akt. , 1998, Current opinion in cell biology.
[38] P. Cohen,et al. Activation of protein kinase B beta and gamma isoforms by insulin in vivo and by 3-phosphoinositide-dependent protein kinase-1 in vitro: comparison with protein kinase B alpha. , 1998, The Biochemical journal.
[39] B. Hemmings. Akt Signaling--Linking Membrane Events to Life and Death Decisions , 1997, Science.
[40] R. Roth,et al. Akt, a Pleckstrin Homology Domain Containing Kinase, Is Activated Primarily by Phosphorylation* , 1996, The Journal of Biological Chemistry.
[41] K. Kameyama,et al. Molecular Cloning and Characterization of a New Member of the RAC Protein Kinase Family: Association of the Pleckstrin Homology Domain of 3 Types of RAC Protein Kinase with Protein Kinase C Subspecies and βγ Subunits of G Proteins , 1995 .
[42] Y. Yazaki,et al. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro. , 1994, Circulation.
[43] J. Robbins,et al. Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. , 1991, The Journal of biological chemistry.